Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bessho

Showing results (81-90 of 87) with videos related to

Pageof 9
Sort By:
You have reached the last page of results.This site can display upto 87 results.
Leukemia|February 3, 2007
Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classificationA Matsuda, U Germing, I Jinnai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 1998
[Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid]K Itoh, W Gotoh, F Yagasaki, et al.
Annals of Hematology|March 21, 2002
Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphomaD Wakao, I Murohashi, K Tominaga, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 13, 1999
[Atypical chronic myeloid leukemia presenting with trilineage dysplasia and IgG (lambda) type monoclonal gammopathy]K Itoh, T Kashimura, Y Kobayashi, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
Control of fracture reduction robot using force/torque measurementT Douke, Y Nakajima, Y Mori, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 24, 1998
[Clinical efficacy of fosfomycin in combination with sulbactam/cefoperazone in the treatment of severe infections complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBT/CPZ]K Kitamura, H Hirai, N Hosoya, et al.
The Japanese Journal of Antibiotics|April 29, 2000
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases]A Urabe, A Fujita, K Aoki, et al.
Pageof 9

Showing results (81-90 of 87) with videos related to

Sort By:
Pageof 9
You have reached the last page of results.This site can display upto 87 results.
Leukemia|February 3, 2007
Improvement of criteria for refractory cytopenia with multilineage dysplasia according to the WHO classification based on prognostic significance of morphological features in patients with refractory anemia according to the FAB classificationA Matsuda, U Germing, I Jinnai, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|May 13, 1998
[Acute promyelocytic leukemia relapse as leukemia cutis shortly after complete remission with all-trans retinoic acid]K Itoh, W Gotoh, F Yagasaki, et al.
Annals of Hematology|March 21, 2002
Serum thymidine kinase and soluble interleukin-2 receptor predict recurrence of malignant lymphomaD Wakao, I Murohashi, K Tominaga, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|April 13, 1999
[Atypical chronic myeloid leukemia presenting with trilineage dysplasia and IgG (lambda) type monoclonal gammopathy]K Itoh, T Kashimura, Y Kobayashi, et al.
Annual International Conference of the IEEE Engineering in Medicine and Biology Society. IEEE Engineering in Medicine and Biology Society. Annual International Conference|January 24, 2009
Control of fracture reduction robot using force/torque measurementT Douke, Y Nakajima, Y Mori, et al.
Kansenshogaku Zasshi. the Journal of the Japanese Association for Infectious Diseases|September 24, 1998
[Clinical efficacy of fosfomycin in combination with sulbactam/cefoperazone in the treatment of severe infections complicated to blood dyscrasia. Working Group of Kanto Combination Therapy for FOM + SBT/CPZ]K Kitamura, H Hirai, N Hosoya, et al.
The Japanese Journal of Antibiotics|April 29, 2000
[Efficacy and safety of cefozopran (CZOP) monotherapy and combination therapy with CZOP and amikacin (AMK) for infections accompanying hematological diseases]A Urabe, A Fujita, K Aoki, et al.
Pageof 9